Vizarsin

Medicinal product

(Invented) name

Vizarsin

Active substance (s)

Sildenafilis

Strength

25 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE03, Sildenafil

Marketing authorisation holder

KRKA, d.d., Novo mesto, Slovėnija

Date of authorisation

2012-05-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Orodispersible tablet	1 vnt.
Sildenafilis	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
52802	66736	1066736	lizdinė plokštelė	N1		Receptinis	EU/1/09/551/013	Netiekiama	-	-	No	-	-
52803	66737	1066737	dalomoji lizdinė plokštelė	N2x1		Receptinis	EU/1/09/551/014	Netiekiama	-	-	No	-	-
52804	66738	1066738	dalomoji lizdinė plokštelė	N4x1		Receptinis	EU/1/09/551/015	Netiekiama	-	-	No	-	-
52805	66739	1066739	dalomoji lizdinė plokštelė	N8x1		Receptinis	EU/1/09/551/016	Netiekiama	-	-	No	-	-
52806	66740	1066740	dalomoji lizdinė plokštelė	N12x1		Receptinis	EU/1/09/551/017	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2012-05-15	Registruotas